Word: rauscher
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...other hope," said Judith Stein of the Cancer Information Service. At present, however, the Institute can treat only eight patients a month and is not accepting new patients. Plans are under way to begin testing the new procedure next year at cancer centers around the country. Dr. Frank Rauscher, a former NCI chief who is now a top official at the American Cancer Society, explained that the excitement in medical circles is for the prospects rather than the accomplishments of IL-2 and other immunological approaches. The results reported last week were a promising opening shot on a new part...
...Steel will not need all the production capability of those two mills. Some industry experts estimate that 20% or more of the company's potential annual steelmaking capacity of 24.6 million tons could be shut down. Observed William Stephens, an analyst who follows LTV for the Rauscher Pierce Refsnes securities firm in Dallas: "This merger won't be one plus one equals two. It will be one plus one equals ll/2 or 1%." Stephens predicted, however, that a slimmed-down company would be able to return to profitability...
...reason for the current caution is the difficulties researchers are encountering in perfecting the use of interferon as a possible cure for cancer. After well over a year of testing on human patients, "interferon hasn't yet done anything better than any other anticancer drug," says Frank Rauscher, senior vice president for research of the American Cancer Society...
Gutterman's application to the A.C.S. reached the desk of Frank Rauscher, who before becoming the society's research chief in 1976 had been director of the National Cancer Institute for five years. At the institute he had been urged repeatedly to "do something about interferon." But Rauscher, himself a virologist, had moved cautiously. He did send an NCI team to Sweden to look at Strander's IF tests with bone cancer, and the institute co-sponsored a 1975 interferon conference in Manhattan. But during his tenure, Rauscher increased the NCI commitment to interferon by a scant $1 million yearly...
...July 1978, as Rauscher surveyed the evidence assembled on his desk, his outlook had changed. New data from Strander, with better controls, were impressive. There were reports by other researchers of positive IF effects on tumors. Cantell had upped his production of interferon, and the evidence accompanying Gutterman's request for $1.5 million to buy IF was persuasive. Rauscher was convinced. He left his office, went upstairs to the A.C.S. executive offices and declared: "It's time to bite the bullet on interferon." The big drive for IF had begun...